SUMMIT HEALTHCARE ACQUISITION CORP. AND YS BIOPHARMA ANNOUNCE EFFECTIVENESS OF REGISTRATION STATEMENT AND EXTRAORDINARY GENERAL MEETING DATE FOR PROPOSED BUSINESS COMBINATION PR Newswire Extraordinary general meeting of Summit Healthcare Acquisition Corp.'s shareholders to b...
Summary Beijing YishengBio will merge with a SPAC vehicle, Summit Healthcare Acquisition, to list on the Nasdaq Exchange at a pre-money equity value of $834 million. Simcere Pharma of Nanjing announced a $507 million out-licensing to Spain’s Almirall for ex-China rights to ...
Special purpose acquisition firm (SPAC) Summit Healthcare Acquisition ( NASDAQ: SMIH ) said on Thursday it would acquire drug maker YS Biopharma in a transaction that is valued at about $834M. YS Biopharma houses YSJA rabies vaccine, which is one of the leading vaccine f...
News, Short Squeeze, Breakout and More Instantly...
Summit Healthcare Acquisition Corp. Company Name:
SMIH Stock Symbol:
NASDAQ Market:
SUMMIT HEALTHCARE ACQUISITION CORP. AND YS BIOPHARMA ANNOUNCE EFFECTIVENESS OF REGISTRATION STATEMENT AND EXTRAORDINARY GENERAL MEETING DATE FOR PROPOSED BUSINESS COMBINATION PR Newswire Extraordinary general meeting of Summit Healthcare Acquisition Corp.'s shareholders to b...